DAX-0,08 % EUR/USD+0,20 % Gold+0,37 % Öl (Brent)-1,01 %

Bavarian NordicAktie

ISIN: DK0015998017 | WKN: 917165 | Symbol: BV3
17,270
 
EUR
10:45:17 Stuttgart
-3,17 %
-0,565 EUR
Geldkurs 12:53:25
17,155 EUR
695 Stk.
Briefkurs 12:54:04
17,320 EUR
373 Stk.
Mehr Daten anzeigen

Bavarian Nordic Chart

Neuigkeiten zur Bavarian Nordic AS Aktie

ZeitTitel
21.03.19

Bavarian Nordic Announces Annual Report 2018
21.02.19

Bavarian Nordic Announces Initiation of Phase 1/2a Clinical Trial of Therapeutic HPV Vaccine Regimen in Collaboration with Janssen
25.01.19

Bavarian Nordic Completes Enrollment of First Stage in Chordoma Phase 2 Trial
18.01.19

Bavarian Nordic Announces Exercise of USD 44 Million Option by the U.S. Government under Contract for Freeze-dried MVA-BN Smallpox Vaccine
21.12.18

Bavarian Nordic Announces FDA Acceptance and Priority Review of Biologics License Application for MVA-BN Smallpox Vaccine
09.11.18

Bavarian Nordic Announces Interim Results for the First Nine Months of 2018
02.11.18

Bavarian Nordic to Host Third Quarter 2018 Results Conference Call
02.11.18

Bavarian Nordic Announces Initiation of Clinical Trial Evaluating the Combination Therapy of CV301 and Durvalumab in Metastatic Colorectal and Pancreatic Cancers
01.11.18

Bavarian Nordic Announces Initiation of Phase 2 Trial of BN-Brachyury for the Treatment of Chordoma
19.09.18

Bavarian Nordic Delivers Smallpox Vaccine to England in Response to Current Monkeypox Cases
18.09.18

Bavarian Nordic Announces Initiation of Phase 2 Trial Evaluating the Combination Therapy of CV301 and Atezolizumab in Bladder Cancer
21.08.18

Importance of Smallpox Vaccination Highlighted in Biopreparedness Exercise
16.08.18

Bavarian Nordic Announces First Half 2018 Results
12.03.18

Avatar faultcode schrieb:
-10% heute --> war das die 2018-Guidance?? Bild: 1213_20180312165457_BN …
09.05.11

Avatar mulake schrieb:
Keiner eine Idee???

Die neusten Nachrichten zu Bavarian Nordic

ZeitTitel
21.03.19
Bavarian Nordic Announces Annual Report 2018
21.02.19
Bavarian Nordic Announces Initiation of Phase 1/2a Clinical Trial of Therapeutic HPV Vaccine Regimen in Collaboration with Janssen
25.01.19
Bavarian Nordic Completes Enrollment of First Stage in Chordoma Phase 2 Trial
18.01.19
Bavarian Nordic Announces Exercise of USD 44 Million Option by the U.S. Government under Contract for Freeze-dried MVA-BN Smallpox Vaccine
21.12.18
Bavarian Nordic Announces FDA Acceptance and Priority Review of Biologics License Application for MVA-BN Smallpox Vaccine
mehr Bavarian Nordic Nachrichten »

Nachrichten aus der Branche Biotechnologie

ZeitTitel
13:00 Uhr
Bone Biologics Receives Human Research Ethics Committee (HREC) Approval for the First Center of a Multicenter Pilot Clinical Trial to Evaluate NB1 (NELL-1/DBX) in Australia
12:05 Uhr
IMV Inc. to Present at Two Upcoming Investor Conferences
11:59 Uhr
Bristol-Myers Squibb Board of Directors Sends Letter to Shareholders Highlighting the Compelling Strategic and Financial Rationale of the Celgene Transaction; Company Provides Additional Investor Materials
11:30 Uhr
Die 10 Top-Aktien des 10-jährigen Bullenmarktes
11:00 Uhr
Karolinska Development's portfolio company Aprea Therapeutics appoints a new Chief Medical Officer
mehr Branchennachrichten »

Indexzugehörigkeit von Bavarian Nordic

WertpapierPerf. %
Nasdaq DM Ex Korea Small Cap EUR Index
-1,05
STOXX Europe Total Market EUR (Net Return)
-1,19
Nasdaq Yewno Global Disruptive Technology Benchmark Index
-1,72
Nasdaq Developed Markets Ex Korea Index
-1,56
STOXX All Europe Total Market EUR (Net Return)
-0,59
Nasdaq DM Ex Korea Small Cap JPY Index Net Total Return
-2,68
Nasdaq DM Ex Korea JPY Index Net Total Return
-2,51
NASDAQ Global Ex United States Small Cap Index EUR Total Return
+0,35
NASDAQ Global Ex United States Small Cap Index Net Total Return
-0,34
STOXX Europe Total Market EUR (Gross Return)
-1,19
Alle zugehörigen Indizes »

Aktienkurs Bavarian Nordic 917165 | DK0015998017

BörsenplatzStuttgart
Letzter Kurs17,270EUR
Performance-3,17 %
Kurszeit10:45:17
Eröffnung17,605EUR
Tageshoch17,605EUR
Tagestief17,270EUR
Vortageskurs17,835EUR
52-Wochen Hoch28,32EUR
52-Wochen Tief16,055EUR
Anzahl Trades3
Performance 1 Monat-10,49 %
Performance 1 Jahr-31,95 %

Stammdaten zu Bavarian Nordic

NameBavarian Nordic AS
KurznameBavarian Nordic
NamenszusatzRegistered Shs
KategorieAktien
AktientypStammaktien
WKN917165
ISINDK0015998017
SymbolBV3
BrancheBiotechnologie
LandDänemark Dänemark
ReferenzwährungDKK
Aktienanzahl32,31 Mio.
Marktkapitalisierung558,00 Mio.EUR

Performance Bavarian Nordic Aktie

ZeitKursPerf.
1 Tag17,270EUR
-3,17 %
1 Woche18,180EUR
-1,90 %
1 Monat19,925EUR
-10,49 %
3 Monate16,075EUR
+10,95 %
6 Monate22,890EUR
-22,08 %
Lfd. Jahr17,115EUR
+4,21 %
1 Jahr26,21EUR
-31,95 %
3 Jahre32,72EUR
-45,48 %
5 Jahre12,955EUR
+37,67 %
10 Jahre9,058EUR
+96,90 %
mehr Performancedaten »
Adresse und Kontaktdaten
NameBavarian Nordic AS
StadtKvistgaard
LandDänemark Dänemark
Webseitewww.bavarian-nordic.com
Aktionäre interessieren sich auch für:
#WertpapierPerf. %
1.
Allianz
-0,03
2.
Bayer
-2,55
3.
Deutsche Telekom
+0,45
4.
Evotec
-1,59
5.
Infineon Technologies
-1,92
6.
Morphosys
-0,73
7.
QSC
+0,81
8.
SAP
-0,60
9.
Qiagen
-0,14
10.
Mologen
-4,41

Handelsinformationen

Haupthandel08:00 - 22:00 Uhr